MDB Capital Holdings, LLC - Class A common (NQ:MDBH)

Collaboration will strengthen the Rising Stars platform through structured intellectual property diligence, commercialization-focused assessments, and year-round founder support

BioNTX and PatentVest Announce Multi-Year Strategic Partnership

September 03, 2026

New Patent Intelligence Report Reveals the Hidden Competitors in the Race to Build AI Smart Glasses

Performance

52-Week Range 62.7% below 52-week high

1.790

1.7552W Low 4.8052W High

1 Week 10.0% below 1-week high

1.751W Low 1.991W High

MDB Capital Holdings, LLC - Class A common (MDBH) traded between $1.75 and $4.80 over the past 52 weeks and last traded at $1.79, 62.7% below its 52-week high. Over the past week it ranged between $1.75 and $1.99.

Past 12 Months

+2.3%

-33.0%

-41.4%

-53.5%

-48.9%

-52.3%

1W +$0.04

1M -$0.88

3M -$1.26

6M -$2.06

YTD -$1.71

1Y -$1.96

MDBH was -52.3% over the past year, -53.5% over six months, -48.9% year to date, +2.3% in the last week.

12 Months vs Market

MDBH

-52.3%

DIA

+12.2%

SPY

+14.8%

QQQ

+18.3%

IWM

+11.4%

Over the past 12 months MDBH returned -52.3% versus DIA (Dow) +12.2%, SPY (S&P 500) +14.8%, QQQ (Nasdaq 100) +18.3% and IWM (Russell 2000) +11.4%.

Volume & Liquidity 0.62× 3-mo avg

Today 1,678 3-mo avg 2.7K

3.4K

2.7K

3.3K

YTD

4.7K

7.4K

MDBH most recently traded 1,678 shares against a 3-month average daily volume of 2.7K.

More News

August 27, 2026

MDB Capital Holdings Provides Second Quarter 2026 Update

August 13, 2026

MDB Capital Holdings to Host Second Quarter 2026 Update Call on Thursday August 13, 2026 at 4:30 p.m. Eastern Time

July 30, 2026

What Is OpenAI Actually Patenting? PatentVest Pulse Analyzes OpenAI's Patent Portfolio

July 23, 2026

PatentVest Publishes New IP Legal Insights Article Examining Why Patent Prosecution Is Ready for AI

July 02, 2026

PatentVest Releases New PatentVest Pulse Report Exploring the Strategic Shift Beyond GLP-1

June 30, 2026

PatentVest to Present at Planet MicroCap Las Vegas on June 17

June 15, 2026

New PatentVest Pulse Report Maps the Emerging Muscle-Preservation Category Expanding the GLP-1 Opportunity

June 04, 2026

MDB Capital to Present at Planet MicroCap Las Vegas 2026 Along with Subsidiary PatentVest and Portfolio Company Buda Juice

June 03, 2026

PatentVest Launches New Case Studies Section Featuring Strategic AI IP Engagement with Docana

May 19, 2026

New PatentVest Pulse Report Maps the Triple-Agonist Race and the Emerging Patent Battle Shaping the Post-GLP-1 Obesity Market

May 08, 2026

Retatrutide Crosses the Surgical Threshold, but the Real Race Has Just Started

April 29, 2026

MDB Capital Holdings Provides 2025 Full Year Update and Shareholder Letter

March 31, 2026

PatentVest Releases New Pulse Report on the $19 Billion Amylin Drug Race Transforming Obesity Treatment

March 31, 2026

PatentVest Highlights New Legal Article on AI Patenting Strategy by Senior Patent Attorney Sarah Cork

March 30, 2026

PatentVest Announces Life Seal Vascular Partnership, Takes Equity Stake in Exchange for IP Intelligence Services

March 30, 2026

MDB Capital Holdings to Host Fourth Quarter and Full Year 2025 Results Conference Call on Tuesday, March 31, 2026 at 4:30 p.m. Eastern Time

March 23, 2026

PatentVest Announces Strategic Intellectual Property Collaboration with Porosome Therapeutics to Strengthen Platform for Secretory Disorder Therapeutics

March 11, 2026

PatentVest Releases New Report on The Oral Small-Molecule GLP-1 Patent Race

February 26, 2026

MDB Capital Holdings Announces Transitions In Its Board of Directors

February 02, 2026

PatentVest Releases New Report on the IP Battle Shaping the $1.8 Trillion Space Economy

January 14, 2026

MDB Capital Holdings Provides Third Quarter 2025 Update

November 20, 2025

MDB Capital Holdings to Host Third Quarter 2025 Update Conference Call on Thursday November 20, 2025, at 4:30 p.m. Eastern Time

November 11, 2025